TCR² Therapeutics to Present at the BMO Prescriptions for Success Healthcare ConferenceGlobeNewsWire • 06/17/20
TCR² Therapeutics Hires Key Business Development and Regulatory Affairs Cell Therapy Experts to Support Strategic ObjectivesGlobeNewsWire • 05/27/20
TCR² Therapeutics Announces Veteran Finance Executive Stephen Webster Joins its Board of DirectorsGlobeNewsWire • 05/04/20
TCR² Therapeutics Announces Immuno-Oncology Pioneer Dr. Axel Hoos Joins its Board of DirectorsGlobeNewsWire • 04/15/20